Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 467 entries
View as:

Biological Markers in Patients With Pancreatic Cancer Experiencing Weight Loss

Phase: N/A Priority: Normal
NCT ID: NCT00899158 Org: User:
Start: 06/30/05 End: 12/31/08 Due: 12/31/09

Thalidomide in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00053300 Org: User:
Start: 08/31/02 End: 04/30/10 Due: 04/30/11

Improving Erectile Function and Quality of Life After Prostate Cancer Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01996852 Org: User:
Start: 07/31/13 End: 08/31/16 Due: 08/31/17

Thiotepa Plus Fludarabine+ Melphalan as the Preparative Regime for Alternative Donor Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT03342196 Org: User:
Start: 03/21/18 End: 06/12/24 Due: 06/12/25

Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02153450 Org: User:
Start: 05/08/15 End: 06/13/20 Due: 06/13/21

Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes

Phase: N/A Priority: Normal
NCT ID: NCT00007904 Org: User:
Start: 07/31/00 End: 09/30/12 Due: 09/30/13

ECM and Monitoring w/ Alio Smart Patch in Cancer Pts Receiving Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06657183 Org: User:
Start: 07/31/25 End: 02/28/26 Due: 02/28/27

Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06738303 Org: User:
Start: 07/31/25 End: 12/31/26 Due: 12/31/27

Intervention for Caregivers of Patients Who Have Recently Undergone HSCT

Phase: N/A Priority: Normal
NCT ID: NCT04639700 Org: User:
Start: 06/30/21 End: 11/30/21 Due: 11/30/22

Hematopoietic Stem Cell Transplant for Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT02065596 Org: User:
Start: 10/19/15 End: 02/17/23 Due: 02/17/24

Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01155583 Org: User:
Start: 06/30/10 End: 11/06/18 Due: 11/06/19

Stereotactic Body Radiation Therapy in Liver Cancer That Cannot be Removed by Surgery or Transplant

Phase: N/A Priority: Normal
NCT ID: NCT01194206 Org: User:
Start: 08/31/10 End: 03/31/12 Due: 03/31/13

Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00005997 Org: User:
Start: 04/30/99 End: 11/30/05 Due: 11/30/06

Unintentional Weight Loss and Cancer: A Prospective Trial of Patient-centered Weight Tracking Combin

Phase: N/A Priority: Normal
NCT ID: NCT05481697 Org: User:
Start: 05/05/23 End: 01/01/26 Due: 01/01/27

Enhanced Recovery After Surgery: A RCT of Perioperative Management of Gynecologic Patients

Phase: N/A Priority: Normal
NCT ID: NCT02357251 Org: User:
Start: 12/12/14 End: 07/03/17 Due: 07/03/18

Defined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01340599 Org: User:
Start: 10/31/06 End: 04/30/07 Due: 04/30/08

Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00003336 Org: User:
Start: 01/31/98 End: 02/28/06 Due: 02/28/07

Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound

Phase: N/A Priority: Normal
NCT ID: NCT05610852 Org: User:
Start: 01/01/24 End: 07/01/28 Due: 07/01/29

Culturally Tailored Decision Aid for Hispanic Patients Diagnosed With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03157947 Org: User:
Start: 08/01/17 End: 12/31/19 Due: 12/31/20

Axitinib Given on an Individualized Schedule for Metastatic Renal Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02579811 Org: User:
Start: 12/30/15 End: 06/20/23 Due: 06/20/24

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

Phase: N/A Priority: Normal
NCT ID: NCT00006379 Org: User:
Start: 06/30/00 End: 10/31/11 Due: 10/31/12

Hearing Loss and Dizziness in Patients Receiving Oxaliplatin for Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00305799 Org: User:
Start: 11/30/05 End: 11/30/14 Due: 11/30/15

Enzalutamide in Patients With High-risk Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01927627 Org: User:
Start: 11/11/13 End: 04/26/17 Due: 04/26/18

Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00258323 Org: User:
Start: 10/31/05 End: 02/28/10 Due: 02/28/11

MRI Before Biopsy in Diagnosing Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02131207 Org: User:
Start: 09/10/14 End: 12/08/17 Due: 12/08/18